Facts about Endosalpingiosis

DOI: 10.4236/ojog.2015.510075   PDF   HTML   XML   2,839 Downloads   3,487 Views  


Endosalpingiosis was first described by Sampson in 1930. However, until recently more and more studies show the convincing evidence that it most probably originates from tubal cells. It has a close relationship with the development of serous tumors, especially low-grade serous carcinoma. The lesion does cause symptoms and signs, such as chronic abdominal pain or tumor-like mass, though it is often found accidently for other gynecologic problems. Occasionally atypical endosalpingiosis needs to be differentiated from a malignancy when it appears in an unusual site with worrying morphologic presentations or under some special circumstances. Owing to the facts that it may evolve quietly and continuously towards serous tumors, and that the lesions at different sites may evolve independently, the outcomes of its evolution can eventually kill the patient. Therefore, a proper recognition of the lesion will translate it into an adequate care for those patients. This review summarizes the most recent findings and makes thoughtful comments.

Share and Cite:

Hou, M. , Chen, L. and Yun, J. (2015) Facts about Endosalpingiosis. Open Journal of Obstetrics and Gynecology, 5, 523-527. doi: 10.4236/ojog.2015.510075.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Li, J., Abushahin, N., Pang, S., Xiang, L., Chambers, S.K., Fadare, O., et al. (2011) Tubal Origin of “Ovarian” Low-Grade Serous Carcinoma. Modern Pathology, 24, 1488-1499.
[2] Morris, H., Emms, M., Visser, T. and Timme, A. (1986) Lymphoid Tissue of the Normal Fallopian Tube—A Form of Mucosal-Associated Lymphoid Tissue (MALT)? International Journal of Gynecological Pathology, 5, 11-22.
[3] Horn, L.C. and Bilek, K. (1995) Frequency and Histogenesis of Pelvic Retroperitoneal Lymph Node Inclusions of the Female Genital Tract. An Immunohistochemical Study of 34 Cases. Pathology, Research and Practice, 191, 991-996.
[4] Li, J., Ning, Y., Abushahin, N., Yuan, Z., Wang, Y., Wang, Y., et al. (2013) Secretory Cell Expansion with Aging: Risk for Pelvic Serous Carcinogenesis. Gynecologic Oncology, 131, 555-560.
[5] Li, J., Fadare, O., Xiang, L., Kong, B. and Zheng, W. (2012) Ovarian Serous Carcinoma: Recent Concepts on Its Origin and Carcinogenesis. Journal of Hematology and Oncology, 5, 8.
[6] Kurman, R.J., Vang, R., Junge, J., Hannibal, C.G., Kjaer, S.K. and Shih, IeM. (2011) Papillary Tubal Hyperplasia: The Putative Precursor of Ovarian Atypical Proliferative (Borderline) Serous Tumors, Noninvasive Implants, and Endosalpingiosis. The American Journal of Surgical Pathology, 35, 1605-1614.
[7] Stolnicu, S., Preda, O., Kinga, S., Marian, C., Nicolau, R., Andrei, S., et al. (2011) Florid, Papillary Endosalpingiosis of the Axillary Lymph Nodes. The Breast Journal, 17, 268-272.
[8] Patonay, B., Semer, D. and Hong, H. (2011) Florid Cystic Endosalpingiosis with Extensive Peritoneal Involvement and Concurrent Bilateral Ovarian Serous Cystadenoma. Journal of Obstetrics and Gynaecology, 31, 773-774.
[9] Rosenberg, P., Nappi, L., Santoro, A., Bufo, P. and Greco, P. (2011) Pelvic Mass-Like Florid Cystic Endosalpingiosis of the Uterus: A Case Report and a Review of Literature. Archives of Gynecology and Obstetrics, 283, 519-523.
[10] Maniar, K.P., Kalir, T.L., Palese, M.A. and Unger, P.D. (2010) Endosalpingiosis of the Urinary Bladder: A Case of Probable Implantative Origin with Characterization of Benign Fallopian Tube Immunohistochemistry. International Journal of Surgical Pathology, 18, 381-383.
[11] Tanahashi, J., Kashima, K., Daa, T., Kondo, Y., Kitano, S. and Yokoyama, S. (2006) Florid Cystic Endosalpingiosis of the Spleen. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 114, 393-398.
[12] Redondo, P., Idoate, M. and Corella, C. (2001) Cutaneous Umbilical Endosalpingiosis with Severe Abdominal Pain. Journal of the European Academy of Dermatology and Venereology, 15, 179-180.
[13] Horn, L.C. and Bilek, K. (1996) Atypical (Carcinoma-Like) and Simple Glandular Inclusions in Retroperitoneal Lymph Nodes. General and Diagnostic Pathology, 141, 319-325.
[14] Zinsser, K.R. and Wheeler, J.E. (1982) Endosalpingiosis in the Omentum: A Study of Autopsy and Surgical Material. The American Journal of Surgical Pathology, 6, 109-117.
[15] Kurman, R.J. and Shih, IeM. (2010) The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory. The American Journal of Surgical Pathology, 34, 433-443.
[16] deHoop, T.A., Mira, J. and Thomas, M.A. (1997) Endosalpingiosis and Chronic Pelvic Pain. The Journal of Reproductive Medicine, 42, 613-616.
[17] Prentice, L., Stewart, A., Mohiuddin, S. and Johnson, N.P. (2012) What Is Endosalpingiosis? Fertility and Sterility, 98, 942-947.
[18] Singh, N., Murali, S. and Zangmo, R. (2014) Florid Cystic Endosalpingiosis, Masquerading as Malignancy in a Young Patient: A Brief Review. BMJ Case Reports, 2014, Published 30 January 2014.
[19] Partyka, L., Steinhoff, M. and Lourenco, A.P. (2014) Endosalpingiosis Presenting as Multiple Pelvic Masses. Journal of Obstetrics and Gynaecology, 34, 279-281.
[20] Liang, J.J., Malpica, A. and Broaddus, R.R. (2007) Florid Cystic Endosalpingiosis Presenting as an Obstructive Colon Mass Mimicking Malignancy: Case Report and Literature Review. Journal of Gastrointestinal Cancer, 38, 83-86.
[21] Corben, A.D., Nehhozina, T., Garg, K., Vallejo, C.E. and Brogi, E. (2010) Endosalpingiosis in Axillary Lymph Nodes: A Possible Pitfall in the Staging of Patients with Breast Carcinoma. The American Journal of Surgical Pathology, 34, 1211-1216.
[22] Singhania, N., Janakiraman, N., Coslett, D. and Ahmad, N. (2014) Endosalpingiosis in Conjunction with Ovarian Serous Cystadenoma Mimicking Metastatic Ovarian Malignancy. The American Journal of Case Reports, 15, 361-363.
[23] Djordjevic, B. and Malpica, A. (2012) Ovarian Serous Tumors of Low Malignant Potential with Nodal Low-Grade Serous Carcinoma. The American Journal of Surgical Pathology, 36, 955-963.
[24] Djordjevic, B., Clement-Kruzel, S., Atkinson, N.E. and Malpica, A. (2010) Nodal Endosalpingiosis in Ovarian Serous Tumors of Low Malignant Potential with Lymph Node Involvement: A Case for a Precursor Lesion. The American Journal of Surgical Pathology, 34, 1442-1448.
[25] McCluggage, W.G., O’Rourke, D., McElhenney, C. and Crooks, M. (2002) Mullerian Papilloma-Like Proliferation Arising in Cystic Pelvic Endosalpingiosis. Human Pathology, 33, 944-946.
[26] McCoubrey, A., Houghton, O., McCallion, K. and McCluggage, W.G. (2005) Serous Adenocarcinoma of the Sigmoid Mesentery Arising in Cystic Endosalpingiosis. Journal of Clinical Pathology, 58, 1221-1223.
[27] Prade, M., Spatz, A., Bentley, R., Duvillard, P., Bognel, C. and Robboy, S.J. (1995) Borderline and Malignant Serous Tumor Arising in Pelvic Lymph Nodes: Evidence of Origin in Benign Glandular Inclusions. International Journal of Gynecological Pathology, 14, 87-91.
[28] Emerson, R.E., Wang, M., Liu, F., Lawrence, W.D., Abdul-Karim, F.W. and Cheng, L. (2007) Molecular Genetic Evidence of an Independent Origin of Serous Low Malignant Potential Implants and Lymph Node Inclusions. International Journal of Gynecological Pathology, 26, 387-394.
[29] Silva, E.G., Tornos, C., Zhuang, Z., Merino, M.J. and Gershenson, D.M. (1998) Tumor Recurrence in Stage I Ovarian Serous Neoplasms of Low Malignant Potential. International Journal of Gynecological Pathology, 17, 1-6.
[30] Malpica, A., Deavers, M.T., Gershenson, D., Tortolero-Luna, G. and Silva, E.G. (2001) Serous Tumors Involving Extra-Abdominal/Extra-Pelvic Sites after the Diagnosis of an Ovarian Serous Neoplasm of Low Malignant Potential. The American Journal of Surgical Pathology, 25, 988-996.
[31] Gadducci, A., Guerrieri, M.E. and Genazzani, A.R. (2012) New Insights on the Pathogenesis of Ovarian Carcinoma: Molecular Basis and Clinical Implications. Gynecological Endocrinology, 28, 582-586.
[32] Pentheroudakis, G. and Pavlidis, N. (2010) Serous Papillary Peritoneal Carcinoma: Unknown Primary Tumour, Ovarian Cancer Counterpart or a Distinct Entity? A Systematic Review. Critical Reviews in Oncology/Hematology, 75, 27-42.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.